These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3936786

  • 1. Effect of the Tc-nitrido group on the behaviour of 99mTc-radiopharmaceuticals.
    Baldas J, Bonnyman J.
    Int J Appl Radiat Isot; 1985 Dec; 36(12):919-23. PubMed ID: 3936786
    [Abstract] [Full Text] [Related]

  • 2. Use of high performance liquid chromatography for the structural identification of technetium-99m radiopharmaceuticals at the NCA level.
    Baldas J, Bonnyman J, Ivanov Z.
    J Nucl Med; 1989 Jul; 30(7):1240-8. PubMed ID: 2738705
    [Abstract] [Full Text] [Related]

  • 3. Substitution reactions of 99mTcNCl-4--A route to a new class of 99mTc-radiopharmaceuticals.
    Baldas J, Bonnyman J.
    Int J Appl Radiat Isot; 1985 Feb; 36(2):133-9. PubMed ID: 2984125
    [Abstract] [Full Text] [Related]

  • 4. Preparation, HPLC studies and biological behaviour of 99mTc- and 99mTcN-radiopharmaceuticals based on quinoline type ligands.
    Baldas J, Bonnyman J.
    Int J Rad Appl Instrum B; 1992 May; 19(4):491-6. PubMed ID: 1526813
    [Abstract] [Full Text] [Related]

  • 5. Structure-distribution relationships of radiopharmaceuticals. Correlation between the reversed-phase capacity factors for Tc-99m phenylcarbamoylmethyliminodiacetic acids and their renal elimination.
    Nunn AD.
    J Chromatogr; 1983 Jan 21; 255():91-100. PubMed ID: 6863425
    [Abstract] [Full Text] [Related]

  • 6. The plasma protein binding of HIDA.
    Nicholson RW, Herman KJ, Shields RA, Testa HJ.
    Eur J Nucl Med; 1980 Aug 21; 5(4):311-2. PubMed ID: 6893182
    [Abstract] [Full Text] [Related]

  • 7. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.
    Hambright P, McRae J, Valk PE, Bearden AJ, Shipley BA.
    J Nucl Med; 1975 Jun 21; 16(6):478-82. PubMed ID: 808594
    [Abstract] [Full Text] [Related]

  • 8. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S, Kalincák M, Machán V.
    Nuklearmedizin; 1981 Dec 21; 20(6):283-9. PubMed ID: 6460222
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules.
    Bolzati C, Benini E, Cazzola E, Jung C, Tisato F, Refosco F, Pietzsch HJ, Spies H, Uccelli L, Duatti A.
    Bioconjug Chem; 2004 Dec 21; 15(3):628-37. PubMed ID: 15149191
    [Abstract] [Full Text] [Related]

  • 10. Preparation and biological behaviour of 99mTc-carbonyl and 99mTc-nitrido complexes of cysteine and some cysteine esters.
    Bonnyman J.
    Nucl Med Biol; 1995 Oct 21; 22(7):943-8. PubMed ID: 8547893
    [Abstract] [Full Text] [Related]

  • 11. Comparison of biokinetics and biliary imaging parameters of four Tc-99m iminodiacetic acid derivatives in normal subjects.
    Bobba VV, Krishnamurthy GT, Kingston E, Brown PH, Eklem M, Turner FE.
    Clin Nucl Med; 1983 Feb 21; 8(2):70-5. PubMed ID: 6825355
    [Abstract] [Full Text] [Related]

  • 12. 99mTc-labelled compounds prepared with molybdenum III as reducing agent.
    Vilcek S, Machán V, Kalincák M.
    Int J Appl Radiat Isot; 1984 Mar 21; 35(3):228-30. PubMed ID: 6425226
    [Abstract] [Full Text] [Related]

  • 13. The investigation of radiopharmaceutical components by fast atom bombardment mass spectrometry: the identification of Tc-HIDA and the epimers of Tc-CO2DADS.
    Costello CE, Brodack JW, Jones AG, Davison A, Johnson DL, Kasina S, Fritzberg AR.
    J Nucl Med; 1983 Apr 21; 24(4):353-5. PubMed ID: 6834138
    [Abstract] [Full Text] [Related]

  • 14. The preparation and composition of HIDA.
    Nicholson RW, Herman KJ, Shields RA, Testa HJ.
    Eur J Nucl Med; 1980 Aug 21; 5(4):313-7. PubMed ID: 6893183
    [Abstract] [Full Text] [Related]

  • 15. Coupling of the 99mtechnetium-nitrido group to monoclonal antibody and use of the complexes for the detection of tumors in mice.
    Kanellos J, Pietersz GA, McKenzie IF, Bonnyman J, Baldas J.
    J Natl Cancer Inst; 1986 Aug 21; 77(2):431-9. PubMed ID: 3461204
    [Abstract] [Full Text] [Related]

  • 16. A structure-distribution-relationship approach leading to the development of Tc-99m mebrofenin: an improved cholescintigraphic agent.
    Nunn AD, Loberg MD, Conley RA.
    J Nucl Med; 1983 May 21; 24(5):423-30. PubMed ID: 6842291
    [Abstract] [Full Text] [Related]

  • 17. 99mTc-labelled Cu(I)-EHDP, a potential skeletal imaging agent.
    Agha NH, Al-Hilli AM, Hassen HA.
    Nuklearmedizin; 1981 Dec 21; 20(6):299-304. PubMed ID: 6799937
    [Abstract] [Full Text] [Related]

  • 18. Long-term clinical investigation of the hepatobiliary agents: 99mTc-HIDA and 99mTc-p-butyl-IDA.
    Agha NH, Al-Hilli AM, Dahir ND, Al-Hissoni MS, Jasim MN, Miran KM, Shubber AH.
    Nuklearmedizin; 1986 Oct 21; 25(5):181-7. PubMed ID: 3797257
    [Abstract] [Full Text] [Related]

  • 19. Fast or slow cholecystokinin infusion in 99mTc HIDA imaging?
    Middleton GW, Williams JH.
    Australas Radiol; 1995 Feb 21; 39(1):100. PubMed ID: 7695518
    [No Abstract] [Full Text] [Related]

  • 20. Application of sodium stannite in the preparation of instant [99mTc]HIDA kit.
    Agha NH, Al-Hilli AM, Dahir ND.
    Int J Appl Radiat Isot; 1984 May 21; 35(5):412-4. PubMed ID: 6735493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.